ClinicalTrials.Veeva

Menu
H

Health Sciences Centre Winnipeg | Rheumatology Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Vancomycin
Clindamycin
Cysteamine
Dabigatran
Ceftriaxone
Moxifloxacin
Tocilizumab
Hydrocortisone
TAK-101
Ivermectin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 16 total trials

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

The main aim of the study is to assess if TAK-101 can reduce gluten related symptoms and immune activation in adult participants with celiac disease...

Enrolling
Celiac Disease
Drug: TAK-101
Dietary Supplement: Gluten

Trial sponsors

Population Health Research Institute (PHRI) logo
U
Boehringer Ingelheim logo
Gilead Sciences logo
H
H
McMaster University logo
S
Takeda logo
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems